CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
3.6. Key Regulation Analysis
3.7. Market Share Analysis
3.8. Patent Landscape
3.9. Regulatory Guidelines
3.10. Value Chain Analysis
CHAPTER 4: LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Bupivacaine
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Ropivacaine
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Lidocaine
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Chloroprocaine
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Prilocaine
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
4.7. Benzocaine
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market share analysis by country
4.8. Other local anesthetics
4.8.1. Key market trends, growth factors and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market share analysis by country
CHAPTER 5: LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Injectable
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Surface Anesthetic
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: LOCAL ANESTHESIA DRUGS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key trends and opportunities
6.2.2. Market size and forecast, by Drugs Type
6.2.3. Market size and forecast, by Application
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Key market trends, growth factors and opportunities
6.2.4.1.2. Market size and forecast, by Drugs Type
6.2.4.1.3. Market size and forecast, by Application
6.2.4.2. Canada
6.2.4.2.1. Key market trends, growth factors and opportunities
6.2.4.2.2. Market size and forecast, by Drugs Type
6.2.4.2.3. Market size and forecast, by Application
6.2.4.3. Mexico
6.2.4.3.1. Key market trends, growth factors and opportunities
6.2.4.3.2. Market size and forecast, by Drugs Type
6.2.4.3.3. Market size and forecast, by Application
6.3. Europe
6.3.1. Key trends and opportunities
6.3.2. Market size and forecast, by Drugs Type
6.3.3. Market size and forecast, by Application
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Key market trends, growth factors and opportunities
6.3.4.1.2. Market size and forecast, by Drugs Type
6.3.4.1.3. Market size and forecast, by Application
6.3.4.2. UK
6.3.4.2.1. Key market trends, growth factors and opportunities
6.3.4.2.2. Market size and forecast, by Drugs Type
6.3.4.2.3. Market size and forecast, by Application
6.3.4.3. France
6.3.4.3.1. Key market trends, growth factors and opportunities
6.3.4.3.2. Market size and forecast, by Drugs Type
6.3.4.3.3. Market size and forecast, by Application
6.3.4.4. Spain
6.3.4.4.1. Key market trends, growth factors and opportunities
6.3.4.4.2. Market size and forecast, by Drugs Type
6.3.4.4.3. Market size and forecast, by Application
6.3.4.5. Italy
6.3.4.5.1. Key market trends, growth factors and opportunities
6.3.4.5.2. Market size and forecast, by Drugs Type
6.3.4.5.3. Market size and forecast, by Application
6.3.4.6. Rest of Europe
6.3.4.6.1. Key market trends, growth factors and opportunities
6.3.4.6.2. Market size and forecast, by Drugs Type
6.3.4.6.3. Market size and forecast, by Application
6.4. Asia-Pacific
6.4.1. Key trends and opportunities
6.4.2. Market size and forecast, by Drugs Type
6.4.3. Market size and forecast, by Application
6.4.4. Market size and forecast, by country
6.4.4.1. China
6.4.4.1.1. Key market trends, growth factors and opportunities
6.4.4.1.2. Market size and forecast, by Drugs Type
6.4.4.1.3. Market size and forecast, by Application
6.4.4.2. Japan
6.4.4.2.1. Key market trends, growth factors and opportunities
6.4.4.2.2. Market size and forecast, by Drugs Type
6.4.4.2.3. Market size and forecast, by Application
6.4.4.3. India
6.4.4.3.1. Key market trends, growth factors and opportunities
6.4.4.3.2. Market size and forecast, by Drugs Type
6.4.4.3.3. Market size and forecast, by Application
6.4.4.4. South Korea
6.4.4.4.1. Key market trends, growth factors and opportunities
6.4.4.4.2. Market size and forecast, by Drugs Type
6.4.4.4.3. Market size and forecast, by Application
6.4.4.5. Australia
6.4.4.5.1. Key market trends, growth factors and opportunities
6.4.4.5.2. Market size and forecast, by Drugs Type
6.4.4.5.3. Market size and forecast, by Application
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Key market trends, growth factors and opportunities
6.4.4.6.2. Market size and forecast, by Drugs Type
6.4.4.6.3. Market size and forecast, by Application
6.5. LAMEA
6.5.1. Key trends and opportunities
6.5.2. Market size and forecast, by Drugs Type
6.5.3. Market size and forecast, by Application
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Key market trends, growth factors and opportunities
6.5.4.1.2. Market size and forecast, by Drugs Type
6.5.4.1.3. Market size and forecast, by Application
6.5.4.2. United Arab Emirates
6.5.4.2.1. Key market trends, growth factors and opportunities
6.5.4.2.2. Market size and forecast, by Drugs Type
6.5.4.2.3. Market size and forecast, by Application
6.5.4.3. Saudi Arabia
6.5.4.3.1. Key market trends, growth factors and opportunities
6.5.4.3.2. Market size and forecast, by Drugs Type
6.5.4.3.3. Market size and forecast, by Application
6.5.4.4. South Africa
6.5.4.4.1. Key market trends, growth factors and opportunities
6.5.4.4.2. Market size and forecast, by Drugs Type
6.5.4.4.3. Market size and forecast, by Application
6.5.4.5. Rest of LAMEA
6.5.4.5.1. Key market trends, growth factors and opportunities
6.5.4.5.2. Market size and forecast, by Drugs Type
6.5.4.5.3. Market size and forecast, by Application
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021
CHAPTER 8: COMPANY PROFILES
8.1. Fresenius Kabi AG
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.2. Novartis AG
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.3. Aspen Holdings
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.4. Sagent Pharmaceuticals
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.5. Pacira Pharmaceuticals, Inc.
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.6. Mylan N.V.
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.7. Teva Pharmaceutical Industries Ltd.
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.8. Pfizer Inc.
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.9. Septodont Healthcare India Pvt. Ltd.
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.10. Baxter International Inc.
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
TABLE 01. GLOBAL LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 02. LOCAL ANESTHESIA DRUGS MARKET FOR BUPIVACAINE, BY REGION, 2021-2031 ($MILLION)
TABLE 03. LOCAL ANESTHESIA DRUGS MARKET FOR ROPIVACAINE, BY REGION, 2021-2031 ($MILLION)
TABLE 04. LOCAL ANESTHESIA DRUGS MARKET FOR LIDOCAINE, BY REGION, 2021-2031 ($MILLION)
TABLE 05. LOCAL ANESTHESIA DRUGS MARKET FOR CHLOROPROCAINE, BY REGION, 2021-2031 ($MILLION)
TABLE 06. LOCAL ANESTHESIA DRUGS MARKET FOR PRILOCAINE, BY REGION, 2021-2031 ($MILLION)
TABLE 07. LOCAL ANESTHESIA DRUGS MARKET FOR BENZOCAINE, BY REGION, 2021-2031 ($MILLION)
TABLE 08. LOCAL ANESTHESIA DRUGS MARKET FOR OTHER LOCAL ANESTHETICS, BY REGION, 2021-2031 ($MILLION)
TABLE 09. GLOBAL LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 10. LOCAL ANESTHESIA DRUGS MARKET FOR INJECTABLE, BY REGION, 2021-2031 ($MILLION)
TABLE 11. LOCAL ANESTHESIA DRUGS MARKET FOR SURFACE ANESTHETIC, BY REGION, 2021-2031 ($MILLION)
TABLE 12. LOCAL ANESTHESIA DRUGS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 13. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 14. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 15. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 16. U.S. LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 17. U.S. LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 18. CANADA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 19. CANADA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 20. MEXICO LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 21. MEXICO LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 22. EUROPE LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 23. EUROPE LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 24. EUROPE LOCAL ANESTHESIA DRUGS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. GERMANY LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 26. GERMANY LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 27. UK LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 28. UK LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 29. FRANCE LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 30. FRANCE LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 31. SPAIN LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 32. SPAIN LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 33. ITALY LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 34. ITALY LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 35. REST OF EUROPE LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 36. REST OF EUROPE LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 37. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 38. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 39. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 40. CHINA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 41. CHINA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 42. JAPAN LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 43. JAPAN LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 44. INDIA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 45. INDIA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 46. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 47. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 48. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 49. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 50. REST OF ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 51. REST OF ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 52. LAMEA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 53. LAMEA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 54. LAMEA LOCAL ANESTHESIA DRUGS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 55. BRAZIL LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 56. BRAZIL LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 57. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 58. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 59. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 60. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 61. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 62. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 63. REST OF LAMEA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 64. REST OF LAMEA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 65. FRESENIUS KABI AG: KEY EXECUTIVES
TABLE 66. FRESENIUS KABI AG: COMPANY SNAPSHOT
TABLE 67. NOVARTIS AG: KEY EXECUTIVES
TABLE 68. NOVARTIS AG: COMPANY SNAPSHOT
TABLE 69. ASPEN HOLDINGS: KEY EXECUTIVES
TABLE 70. ASPEN HOLDINGS: COMPANY SNAPSHOT
TABLE 71. SAGENT PHARMACEUTICALS: KEY EXECUTIVES
TABLE 72. SAGENT PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 73. PACIRA PHARMACEUTICALS, INC.: KEY EXECUTIVES
TABLE 74. PACIRA PHARMACEUTICALS, INC.: COMPANY SNAPSHOT
TABLE 75. MYLAN N.V.: KEY EXECUTIVES
TABLE 76. MYLAN N.V.: COMPANY SNAPSHOT
TABLE 77. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY EXECUTIVES
TABLE 78. TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
TABLE 79. PFIZER INC.: KEY EXECUTIVES
TABLE 80. PFIZER INC.: COMPANY SNAPSHOT
TABLE 81. SEPTODONT HEALTHCARE INDIA PVT. LTD.: KEY EXECUTIVES
TABLE 82. SEPTODONT HEALTHCARE INDIA PVT. LTD.: COMPANY SNAPSHOT
TABLE 83. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
TABLE 84. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
